Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Douae Bensaid"'
Autor:
Douae Bensaid, Thibaut Blondy, Sophie Deshayes, Virginie Dehame, Philippe Bertrand, Marc Grégoire, Mohammed Errami, Christophe Blanquart
Publikováno v:
Clinical Epigenetics, Vol 10, Iss 1, Pp 1-11 (2018)
Abstract Background Malignant pleural mesothelioma (MPM) is a very rare and highly aggressive cancer of the pleura associated in most cases with asbestos exposure. To date, no really efficient treatments are available for this pathology. Recently, it
Externí odkaz:
https://doaj.org/article/793ab1a714aa4733ae097b99ee25a5ce
Publikováno v:
Integrative Cancer Science and Therapeutics. 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f46945afc7880103dfef9ab8ecfd9628
https://doi.org/10.15761/icst.1000331
https://doi.org/10.15761/icst.1000331
Autor:
Douae Bensaid, Blondy, Thibaut, Deshayes, Sophie, Dehame, Virginie, Bertrand, Philippe, GrĂŠgoire, Marc, Errami, Mohammed, Blanquart, Christophe
Table S3. HDACi AUC on immune cells. (DOCX 14 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32497847cb7220707f5db11ce19f7467
Autor:
Douae Bensaid, Blondy, Thibaut, Deshayes, Sophie, Dehame, Virginie, Bertrand, Philippe, Grégoire, Marc, Errami, Mohammed, Blanquart, Christophe
Figure S3. HDACi increase decitabine-induced CTA expression in Meso96 cells. Meso96 cells were treated with: VPA 5 mM, SAHA 2.5 μM, ODB 7.5 μM, NODB 2.5 μM, ODH 2.5 μM, and NODH 25 nM (48 h) in combination or not with decitabine (5-aza) 500 nM (7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f370ea667e2633f6021fd13613cdcdb
Autor:
Douae Bensaid, Blondy, Thibaut, Deshayes, Sophie, Dehame, Virginie, Bertrand, Philippe, Grégoire, Marc, Errami, Mohammed, Blanquart, Christophe
Figure S8. Effect of decitabine on Treg and NK cells. Lymphocytes obtained by elutriation were treated with decitabine (5-aza) 500 nM (72 h). Figure are examples of results obtained on A) natural killer cells (NK) and B) regulatory T cells (Treg) usi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5a5077e3e9ffcc46ed67e23cc782f78
Autor:
Douae Bensaid, Blondy, Thibaut, Deshayes, Sophie, Dehame, Virginie, Bertrand, Philippe, Grégoire, Marc, Errami, Mohammed, Blanquart, Christophe
Figure S4. Expression of HLA ABC in Meso96 treated with decitabine/HDACi combinations. Meso96 were treated with: VPA 5 mM, SAHA 2.5 μM, ODB 7.5 μM, NODB 2.5 μM, ODH 2.5 μM, and NODH 25 nM (48 h) in combination or not with decitabine (5-aza) 500 n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6b953ada132ab990fd960c36458eddc
Autor:
Douae Bensaid, Blondy, Thibaut, Deshayes, Sophie, Dehame, Virginie, Bertrand, Philippe, Grégoire, Marc, Errami, Mohammed, Blanquart, Christophe
Figure S5. HDACi increase decitabine-induced CTA expression in Meso34 cells. Meso34 cells were treated with: VPA 5 mM, SAHA 2.5 μM, ODB 7.5 μM, NODB 2.5 μM, ODH 2.5 μM, and NODH 25 nM (48 h) in combination or not with decitabine (5-aza) 500 nM (7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a90caf4ffade1166470f923c6751fd63
Autor:
Douae Bensaid, Blondy, Thibaut, Deshayes, Sophie, Dehame, Virginie, Bertrand, Philippe, Grégoire, Marc, Errami, Mohammed, Blanquart, Christophe
Figure S6. HDACi increase decitabine-induced CTA expression in Meso45 cells. Meso45 cells were treated with: VPA 5 mM, SAHA 2.5 μM, ODB 7.5 μM, NODB 2.5 μM, ODH 2.5 μM, and NODH 25 nM (48 h) in combination or not with decitabine (5-aza) 500 nM (7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::090072d5ae058a935a8373f149087fb5
Autor:
Douae Bensaid, Blondy, Thibaut, Deshayes, Sophie, Dehame, Virginie, Bertrand, Philippe, Grégoire, Marc, Errami, Mohammed, Blanquart, Christophe
Figure S1. Effect of HDAC inhibitors on naïve and memory T-cells. Lymphocytes obtained by elutriation were treated with HDACi at the following concentrations for 48 h: VPA 5 mM, SAHA 1 μM, ODB 32 μM, NODB 8 μM, ODH 4 μM, and NODH 50 nM. Graphics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a7b423be926d1811582b33d79ccec84
Autor:
Douae Bensaid, Blondy, Thibaut, Deshayes, Sophie, Dehame, Virginie, Bertrand, Philippe, Grégoire, Marc, Errami, Mohammed, Blanquart, Christophe
Figure S2. Effect of decitabine and HDACi, in combination or not, on MPM cell growth. MPM cells were treated with: VPA 5 mM, SAHA 2.5 μM, ODB 7.5 μM, NODB 2.5 μM, ODH 2.5 μM, and NODH 25 nM (48 h) in combination or not with decitabine (5-aza) 500
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e502e995953c77a7acb5e5df0858429